July 17, 2024

Stone Fragmentation Devices are the largest segment driving the growth of the Urolithiasis

Management Devices Market.

The global Urolithiasis Management Devices Market is estimated to be valued at US$ 1,694.7 Mn or Million in 2023 and is expected to exhibit a CAGR of 4.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Urolithiasis management devices are used for breaking and removing kidney stones present in the urinary tract. Various devices used include lithotripsy devices, urinary stone removal devices, and ureteral stents or nephrostomy catheters. These help in minimally invasive treatments for kidney stones thereby reducing trauma and hospital stay.

Market key trends:
One of the key trends in the Urolithiasis Management Devices Market is the growing adoption of minimally invasive procedures for stone removal. Minimally invasive surgeries such as ureteroscopy, percutaneous nephrolithotomy, and extracorporeal shockwave lithotripsy offer advantages such as smaller incisions, lesser trauma, shorter hospital stay, and quicker recovery. They reduce complications associated with open surgeries. The availability of advanced devices with improved efficacy and safety profiles is further driving the uptake of minimally invasive surgeries.
Market key trends:
The global urolithiasis management devices market is witnessing rising demand for minimally invasive surgeries for treating urolithiasis. Procedures such as extracorporeal shock wave lithotripsy (ESWL), ureteroscopy, and percutaneous nephrolithotomy are gaining popularity due to benefits such as less pain, shorter hospital stay, and quick recovery time. Furthermore, technological advancements in lithotripsy devices such as the use of lasers and digital imaging systems for improved accuracy and effectiveness of stone fragmentation are supporting the adoption of these devices.

SWOT Analysis
Strength: The increasing preference for minimally invasive surgeries reduces complications and recovery time.
Weakness: High cost of sophisticated devices limits widespread adoption.
Opportunity: Growing awareness about urinary stones and rising healthcare expenditure in developing nations create growth opportunities.
Threats: presence of alternative treatment options like medications and certain risks associated with complex surgeries.

Key Takeaways
The global urolithiasis management devices market size was valued at US$ 1,694.7 Mn in 2023 and is expected to reach over US$ 2,500 Mn by 2030, expanding at a CAGR of 4.8% during the forecast period. The rising geriatric population susceptible to urinary stones and technological advancement of devices are major factors driving the market.

Regional analysis: North America dominated the global market in 2023 due to rapid adoption of advanced devices and favorable reimbursement policies in the region. Asia Pacific is expected to witness the highest growth during the forecast period motivated by growing healthcare infrastructure, unmet clinical needs, and improving access to healthcare in developing countries such as India and China.

Key players: Some of the prominent players operating in the urolithiasis management devices market include Lumenis Ltd., Boston Scientific Corp, BD, Cook Medical, Karl Storz, Allengers Medical Systems, Inc, Olympus Corporation, Electro Medical Systems SA, Dornier MedTech GmbH, Direx Group., HealthTronics, Inc., CONMED Corporation., Applaud Medical, Inc., Potent Medical., and other prominent players. These players are focusing on new product launches and geographic expansion to gain a competitive advantage in the market.